Our Research

Malaria is an ancient scourge of humanity and one of the deadliest infectious diseases worldwide. High-throughput genomics has greatly improved our knowledge of the malaria parasite, Plasmodium falciparum, but functional and mechanistic understanding of the proteins and metabolic pathways encoded by the parasite’s highly divergent genome has lagged far behind. All clinical symptoms of malaria arise during parasite infection of erythrocytes, and this developmental stage can be readily cultured in vitro to enable in-depth study of the molecular factors and cellular features that equip Plasmodium parasites to survive and proliferate within host erythrocytes.

Our research has two general goals:

  1. To develop and apply diverse cellular, genetic, and biochemical tools to uncover general metabolic principles and adaptations governing the unique biology of P. falciparum parasites during infection of human red blood cells. 
  2. To apply this knowledge to develop novel strategies to target this virulent pathogen.

Our work is highly interdisciplinary and spans multiple areas of cell biology, genetics, chemical biology, protein biochemistry, and biophysics. We use CRISPR/Cas9-based genome editing to tag endogenous parasite proteins for localization and trafficking studies and for conditional regulation of protein expression in blood-stage parasites. We exploit the power of in vitro biochemistry to interrogate the functional properties of purified proteins and reconstituted biochemical pathways. As appropriate, we also carry out parallel studies in bacteria and yeast or mammalian cells to develop tools and to compare and contrast general metabolic principles in discrete prokaryotic and eukaryotic organisms.

Heme metabolism

We study the cellular mechanisms by which parasites acquire, traffic, and utilize the essential cofactor heme. 

  • Parasites express a complete heme biosynthesis pathway but do not require its activity during blood-stage infection, suggesting an ability to scavenge host heme. We are developing and applying genetically encoded heme biosensors and chemical probes to dissect the pathways of heme trafficking and acquisition within parasites. 
  • Although heme biosynthesis is not essential for parasite growth, our prior work suggests that chemical stimulation of porphyrin biosynthesis can be harnessed to kill parasites using light. We are developing combinatorial chemiluminescent strategies to target porphyrin synthesis for antimalarial chemotherapy.
  • Plasmodium parasites require heme as a cofactor for cytochrome-dependent electron transport in the mitochondrion. We employ a battery of in-parasite and in vitro approaches to dissect and understand the maturation of the critical c-type cytochrome components. To clarify the broader landscape of heme utilization by parasites, we are taking cellular and biochemical approaches to test the functions of diverse non-canonical heme proteins identified within the highly divergent parasite genome.

Organelle function and adaptation

Plasmodium parasites contain a single mitochondrion and a non-photosynthetic plant-like plastid, called the apicoplast. These organelles carry out key metabolic processes but have unusual structural and functional features relative to other eukaryotic organisms. We are applying a suite of genetic, chemical, and biophysical probes to dissect and understand the functional properties and metabolic adaptations of discrete biochemical pathways within these organelles across multiple stages of sexual and asexual parasite development. Ultimately, our goals are to broaden fundamental knowledge of fascinating and divergent parasite biology and to uncover novel therapeutic opportunities.